Data obtained from patients with NASH reported that the nuclear abundance of Nrf2 protein was increased in the liver, and the hepatic expression of γ-glutamylcysteine synthetase, Gpx2, Txn1, and HO-1 was upregulated [62]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.